These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11352187)

  • 1. Endstage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral.
    Crook ED; Harris J; Oliver B; Fleischman E; Crenshaw G; Taylor R
    J Investig Med; 2001 May; 49(3):284-91. PubMed ID: 11352187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced diabetic nephropathy disproportionately affects African-American females: cross-sectional analysis and determinants of renal survival in an academic renal clinic.
    Crook ED; Wofford P; Oliver B
    Ethn Dis; 2003; 13(1):28-33. PubMed ID: 12723009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative effects of angiotensin converting enzyme inhibitors and calcium antagonists in advanced diabetic nephropathy.
    Crook ED; Preddie DC
    Ethn Dis; 2004; 14(1):87-93. PubMed ID: 15002928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of enalapril on advanced diabetic nephropathy in African-American females.
    Crook ED; Harris J; Oliver B; Taylor R
    Ethn Dis; 2001; 11(2):211-6. PubMed ID: 11455995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: effects on risk of diabetes and its complications.
    Crook ED; Genous L; Oliver B
    J Investig Med; 2003 Nov; 51(6):360-5. PubMed ID: 14686639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
    Crook ED; Patel S
    Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic.
    Menon R; Mohd Noor FS; Draman CR; Seman MR; Ghani AS
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1109-14. PubMed ID: 22982937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy.
    Satko SG; Langefeld CD; Daeihagh P; Bowden DW; Rich SS; Freedman BI
    Am J Kidney Dis; 2002 Sep; 40(3):489-94. PubMed ID: 12200799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan reducing incidence of endstage renal disease in diabetic nephropathy trial (ORIENT): rationale and study design.
    Imai E; Ito S; Haneda M; Chan JC; Makino H;
    Hypertens Res; 2006 Sep; 29(9):703-9. PubMed ID: 17249526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial clustering of end-stage renal disease in Mississippi.
    Butkus DE
    J Miss State Med Assoc; 2002 Mar; 43(3):71-7. PubMed ID: 11944578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1975-1984.
    Kappel DF; Van Tuinen M
    Am J Kidney Dis; 1986 Oct; 8(4):234-8. PubMed ID: 3766529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors.
    Crenshaw G; Bigler S; Salem M; Crook ED
    Am J Med Sci; 2000 May; 319(5):320-5. PubMed ID: 10830556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic nephropathy in African Americans.
    Crook ED
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):132S-138S. PubMed ID: 11411748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.
    Hunsicker LG
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S12-7. PubMed ID: 15369420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. For the patient. African-American women at risk of diabetes and kidney disease. Advanced diabetic nephropathy disproportionately affects African-American females: cross-sectional analysis and determinants of renal survival in an academic renal clinic.
    Crook ED; Wofford P; Oliver B
    Ethn Dis; 2003; 13(1):147. PubMed ID: 12723024
    [No Abstract]   [Full Text] [Related]  

  • 16. Using the right medication to lower blood pressure and chance for kidney disease.
    Crook ED; Preddie DC
    Ethn Dis; 2004; 14(1):161. PubMed ID: 15002940
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetic renal disease in African Americans.
    Crook ED
    Am J Med Sci; 2002 Feb; 323(2):78-84. PubMed ID: 11863083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of hypertensive end-stage renal disease: effect of patient's race.
    Perneger TV; Whelton PK; Klag MJ; Rossiter KA
    Am J Epidemiol; 1995 Jan; 141(1):10-5. PubMed ID: 7801960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which factors actually influence the development and progression of overt nephropathy in Nigerian diabetics?
    Ibrahim A; Arogundade FA; Sanusi AA; Ikem R; Akintomide AO; Akinsola AA
    Cent Afr J Med; 2009; 55(5-8):28-34. PubMed ID: 21977825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.